Formulation Development of a Nucleotide Phosphoramidate

June 2, 2003

Manoj Maniar, PhD, is senior director at the formulation and drug delivery group, BioSciences Division, SRI International.

Pharmaceutical Technology, Pharmaceutical Technology-06-02-2003, Volume 27, Issue 6

A small-volume parenteral formulation of NB1011, an enzyme-catalyzed therapeutic activation compound, was successfully developed for intravenous administration.